{"timestamp": 1771600196.6551905, "value": {"ticker": "SGMO", "company_name": "Sangamo Therapeutics, Inc.", "short_name": "Sangamo Therapeutics, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 136742832, "float_shares": 329828533, "shares_outstanding": 371684781, "short_ratio": 4.18, "short_percent_of_float": 0.073699996, "shares_short": 24620718, "shares_short_prior": 21156433, "insider_percent_held": 0.02082, "institution_percent_held": 0.17534, "total_cash": 29616000, "total_debt": 25424000, "total_revenue": 32875000, "revenue_growth": -0.988, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": -2.1910899, "operating_margins": -61.19277, "debt_to_equity": 407.24, "current_ratio": 0.879, "book_value": 0.019, "price_to_book": 19.36316, "operating_cashflow": -76156000, "free_cashflow": -38798752, "price": 0.3679, "52w_high": 1.24, "52w_low": 0.35, "avg_volume": 7230883, "avg_volume_10d": 8755780, "full_time_employees": 183, "audit_risk": 8, "overall_risk": 4}}